COVID-19 disease. COVID-19
Conditions
Interventions
Intervention 1: Intervention group: Patients with covid 19 were treated daily with aspirin 80 mg for three months. Intervention 2: Control group: Patients with covid19 received standard treatment for
Sponsors
Rasht University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: All patients admitted with a diagnosis of Covid 19 based on CT scan or PCR Over 18 years
Exclusion criteria
Exclusion criteria: patients admitted to the ICU. Patients with a history of ulcers and gastrointestinal problems. Patients receiving aspirin. patients with a history of thrombotic events such as heart attack or stroke or a history of atrial fibrillation, congestive heart failure, active bleeding or coagulation disorders such as thrombocytopenia.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Thromboembolic events. Timepoint: Thromboembolic events at the beginning of the study and 3 and 6 months later. Method of measurement: Clinical signs and laboratory tests.;Cardiovascular accidents. Timepoint: Cardiovascular accidents at the beginning of the study and 3 and 6 months later. Method of measurement: Electrocardiography, Echocardiography.;Brain accidents. Timepoint: Brain accidents at the beginning of the study and 3 and 6 months later. Method of measurement: CT scan. | — |
Secondary
| Measure | Time frame |
|---|---|
| Death. Timepoint: 6 months later. Method of measurement: Phone call with the patient. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactZahra ahmadnia
Rasht University of Medical Sciences
Outcome results
None listed